An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial

• Status: Completed
• Trial end date: 2020-04-27

Summary

The present study is a randomized clinical trial, with the approval of the ethics committee will be conducted on patients who have a positive test confirming COVID-19 in Loghman Hakim Medical Education Center in Tehran. Patients will be randomly assigned to the three arms of the study and after completing the course of treatment and collecting and analyzing the necessary information from each patient, the results of the study will be published both on this site and in the form of an article in a reputable international journal.

• Phase: Phase 2

Details

• Lead Sponsor: Shahid Beheshti University of Medical Sciences
• Treatments: Hydroxychloroquine; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Interferons; Lopinavir; Ritonavir